ABSTRACT
The results of the operative treatment of 277 patients with atrioventricular block and sick sinus syndrome were analysed. The primary implantation of the electrocardiostimulators (ECS) was performed in 211 (73.5%), the repeated one--in 76 (26.5%) patients. The complications of endocardial electrocardiostimulation developed in 58 (17.3%) patients, of them in 39 (14%), the repeated operative intervention was performed. Most frequently, the complications were conditioned by the quality of electrodes and ECG.
Subject(s)
Cardiac Pacing, Artificial/adverse effects , Heart Block/therapy , Sick Sinus Syndrome/therapy , Aged , Electrodes, Implanted , Equipment Failure , Humans , Middle Aged , Pacemaker, Artificial , ReplantationSubject(s)
Adams-Stokes Syndrome/etiology , Pacemaker, Artificial/adverse effects , Endocardium , Equipment Failure , Humans , Male , Middle AgedABSTRACT
Neurophysiologic effects of a course of treatment with reserpin (0.5-0.75 mg/day), dopegyt (750-1500 mg/day), clophelin (0.3-0.6 mg/day), anaprilin (80-160 mg/day), hydrochlorothiazide (25-100 mg/day) were examined in 294 patients with first- and second-stage essential hypertension (EH), using the correction test and the numbers-finding test, determination of the highest data processing rate by the Diagnoz-2 device, and the time of response to sound and light stimulation under monotonous conditions. There were no significant differences in test results between EH patients treated with the above-mentioned drugs and the placebo-treated ones. Neither single doses, nor courses taken in hospital (1 to 3 weeks) or outpatient clinic (6 to 36 months) produced any regular suppressive effect on the neurophysiologic status of EH patients.
